Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.

Park J, Kim KI, Koh Y, Won NH, Oh JM, Lee DS, Kim BK, Ahn KS, Yoon SS. Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model. Exp Hematol. 2010 Sep; 38(9):773-81.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Benzamides
Blast Crisis
Bone Marrow Cells
Cattle
Cell Line, Tumor
Disease Models, Animal
Drug Resistance, Neoplasm
Female
Fusion Proteins, bcr-abl
Humans
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Mice
Mice, Inbred NOD
Mice, SCID
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Neoplasm Transplantation
Phosphorylation
Piperazines
Pyrimidines
Signal Transduction
Transplantation, Heterologous

authors with profiles

Juwon Park

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support